0020

Daan Gene Co., Ltd. (002030)

Market Closed
8 Dec, 06:57
XSHE XSHE
¥
6. 42
-0.01
-0.16%
¥
9.45B Market Cap
35.97 P/E Ratio
0.07% Div Yield
11,660,121 Volume
0.74 Eps
¥ 6.43
Previous Close
Day Range
6.4 6.48
Year Range
5.11 7.77
Want to track 002030 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002030 closed today lower at ¥6.42, a decrease of 0.16% from yesterday's close, completing a monthly decrease of -1.68% or ¥0.11. Over the past 12 months, 002030 stock gained 13.03%.
002030 is not paying dividends to its shareholders.
The last earnings report, released on Oct 31, 2025, exceeded the consensus estimates by 0.03%. On average, the company has fell short of earnings expectations by -0.05%, based on the last three reports.
Daan Gene Co., Ltd. has completed 2 stock splits, with the recent split occurring on May 19, 2021.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).

002030 Chart

Similar

Guangzhou Wondfo Biotech Co., Ltd.
¥ 20.82
+0.1%
China Reform Health Management Co., Ltd.
¥ 9.76
-0.1%
Acro Biosystems Co., Ltd.
¥ 55.44
-0.11%
EIT Environmental Development Group Co., Ltd.
¥ 23
-0.35%
Huapont Life Sciences Co., Ltd.
¥ 4.86
0%

Daan Gene Co., Ltd. (002030) FAQ

What is the stock price today?

The current price is ¥6.42.

On which exchange is it traded?

Daan Gene Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002030.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.07%.

What is its market cap?

As of today, the market cap is 9.45B.

Has Daan Gene Co., Ltd. ever had a stock split?

Daan Gene Co., Ltd. had 2 splits and the recent split was on May 19, 2021.

Daan Gene Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Ms. Luo Huang CEO
XSHE Exchange
CNE000001KP1 ISIN
CN Country
1,730 Employees
- Last Dividend
19 May 2021 Last Split
23 Jul 2004 IPO Date

Overview

Daan Gene Co., Ltd., a comprehensive entity based in Guangzhou, China, operates primarily in the biotechnological and biomedical fields. Founded in 1988, the company was originally known as Da An Gene Co., Ltd. of Sun Yat-Sen University. It focuses on the research, development, manufacturing, and commercialization of clinical test reagents, instruments, and corresponding consumables. Daan Gene has diversified its operations into two major segments: Biological Products and Related Business, and Financial Business. This diversification reflects not only its core scientific endeavors but also an immersion into financial and consultancy services tailored for the healthcare sector. Among its notable activities are its innovation-driven approaches towards addressing major public health issues, including infectious diseases and cancer, through advanced diagnostics and medical services.

Products and Services

  • Diagnostic Reagents and Instruments:

    A wide array of reagents and diagnostic instruments for various medical conditions and tests, including hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, and COVID-19. The company emphasizes the crucial role of accurate diagnostics in healthcare through its molecular diagnosis systems, such as polymerase chain reaction (PCR) systems, chemiluminescence immunoassay analyzers, and nucleic acid extraction methods.

  • COVID-19 Specific Products:

    During the COVID-19 pandemic, the company leveraged its technological capabilities to offer rapid test kits and viral transport mediums, contributing to global efforts to curb the spread of the virus.

  • Tumor and Pathology Testing Products:

    Daan Gene provides innovative solutions for cancer diagnosis and pathology testing, including liquid-based cytology production tools, automatic sample transfer machines, and auto biochemistry analyzers. These products represent the company's commitment to advancing cancer detection and treatment.

  • Medical Laboratory and Health Consultation Services:

    Beyond physical products, Daan Gene also offers a suite of health services encompassing genetic susceptibility gene testing, tumor marker testing, and routine physical examinations. These services aim to promote preventive healthcare and personalized medicine, aligning with modern trends in the healthcare industry.

  • Brand and Subsidiary Products:

    The company's diverse product range is marketed under several brands, including Daan Gene, Darui Biology, LBP, and Zhongshan Bio-Tech, covering a broad spectrum of medical and pathology tests.

  • Financial and Consultancy Services:

    Expanding beyond biotechnological products, Daan Gene engages in an array of services related to hospital investment management, insurance, finance leasing, commercial factoring, and consulting. These services underline the company's intricate involvement in the broader health industry, facilitating access to healthcare advancements.

Contact Information

Address: No.19, Xiangshan Road, Guangzhou, China, 510665
Phone: 86 20 3229 0789